V CompBrief BY VELARION

Chair of the Board · Deciphera Pharmaceuticals, Inc. (DCPH)

Ron Squarer director compensation at Deciphera (FY2023): $403K

Fiscal year 2023 director compensation for Ron Squarer at Deciphera Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 25, 2024 (DEF 14A). Open the filing on EDGAR.

Free

Get Ron Squarer’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Ron Squarer and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Deciphera Pharmaceuticals Director Compensation Table · the one fiscal year held
In US dollars, as Deciphera Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2023$74,702$0$328,593$0$403,295

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Deciphera Pharmaceuticals, Inc. DEF 14A filed April 25, 2024, accession 0001654151-24-000012, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Deciphera Pharmaceuticals, Inc. filed document, accession 0001654151-24-000012. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2024.

Get the Deciphera Pharmaceuticals Board Governance Report

$403,295 Ron Squarer, FY2023 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 25, 2024 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2023

Deciphera Pharmaceuticals pays directors a $50,000 cash retainer.

Committees

FY2023 · as the proxy prints them

Audit

The rest of the Deciphera Pharmaceuticals board

FY2023 · as the company reported each
DirectorRoleFY2023 total
Dennis L. WalshIndependent Director$386,053
Edward J. Benz Jr., M.DIndependent Director$396,093
Frank S. FriedmanIndependent Director$382,303
James A. Bristol, Ph.DIndependent Director$414,767
John R. MartinIndependent Director$388,593
Patricia L. AllenIndependent Director$398,553
Steven L. HoerterDirector—
Susan L. Kelley, M.DIndependent Director$396,053

The full Deciphera Pharmaceuticals compensation record

free company brief
Deciphera Pharmaceuticals, Inc. (DCPH) — free Compensation Briefevery named executive and director, board pay, say-on-pay, the peer group

This page is one director within Deciphera Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the Deciphera Pharmaceuticals proxy · each links to its own free brief

Order DCPH

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report